Gain Therapeutics, Inc.

NasdaqGM:GANX Stock Report

Market Cap: US$48.3m

Gain Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:GANX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Aug 24BuyUS$14,544Gene MackIndividual14,400US$1.01
09 Aug 24BuyUS$49,940Khalid IslamIndividual50,000US$1.00
01 Jul 24BuyUS$20,670Eric RichmanIndividual17,000US$1.23
28 Mar 24BuyUS$115,770Jeffrey RileyIndividual30,000US$3.86
07 Dec 23SellUS$4,550Matthias AlderIndividual1,820US$2.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GANX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,300,7825.09%
Institutions1,677,7856.57%
General Public22,556,89388.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75.4%.

Top Shareholders

Top 25 shareholders own 11.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.65%
Khalid Islam
930,784US$1.8m5.68%no data
2.22%
Greenlight Capital, Inc.
566,130US$1.1m0%0.04%
1.31%
Gotham Asset Management, LLC
334,592US$632.6k0%0.01%
1.19%
Eric Richman
304,458US$575.6k5.91%no data
1.07%
Geode Capital Management, LLC
271,972US$514.2k48%no data
0.57%
The Vanguard Group, Inc.
145,217US$274.5k0%no data
0.33%
BlackRock, Inc.
84,924US$160.6k0.36%no data
0.21%
Edward Jones Trust Company
53,500US$101.1k664%no data
0.21%
Renaissance Technologies LLC
53,264US$100.7k-55.1%no data
0.18%
Northern Trust Global Investments
44,944US$85.0k0%no data
0.14%
Prelude Capital Management, LLC
35,820US$67.7k0%no data
0.13%
State Street Global Advisors, Inc.
34,437US$65.1k0%no data
0.12%
Jeffrey Riley
30,000US$56.7k0%no data
0.083%
Matthias Alder
21,140US$40.0k0%no data
0.06%
Sandhill Capital Partners LLC
15,400US$29.1k0%no data
0.056%
Gene Mack
14,400US$27.2k0%no data
0.033%
UBS Asset Management AG
8,455US$16.0k-26%no data
0.019%
Tower Research Capital Europe Limited
4,842US$9.2k180%no data
0.019%
Simplex Trading, LLC, Asset Management Arm
4,801US$9.1k-47%no data
0.019%
Morgan Stanley, Investment Banking and Brokerage Investments
4,800US$9.1k45.5%no data
0.017%
Creekmur Asset Management, LLC
4,440US$8.4k0%no data
0.013%
Merrill Lynch & Co. Inc., Banking Investments
3,375US$6.4k0%no data
0.01%
Wells Fargo & Company, Securities and Brokerage Investments
2,650US$5.0k0%no data
0.0093%
Lord, Abbett & Co. LLC
2,374US$4.5k0%no data
0.0055%
Group One Trading LP, Asset Management Arm
1,401US$2.7k-81.1%no data